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Abstract
Introduction: In patients with multiple sclerosis (MS), conventional magnetic
resonance imaging (MRI) provides only limited insights into the nature of brain
damage with modest clinic-radiological correlation. In this study, we applied
recent advances in MRI techniques to study brain microstructural alterations in
early relapsing-remitting MS (RRMS) patients with minor deficits. Further, we
investigated the potential use of advanced MRI to predict functional perfor-
mances in these patients. Methods: Brain relaxometry (T1, T2, T2*) and magneti-
zation transfer MRI were performed at 3T in 36 RRMS patients and 18 healthy
controls (HC). Multicontrast analysis was used to assess for microstructural alter-
ations in normal-appearing (NA) tissue and lesions. A generalized linear model
was computed to predict clinical performance in patients using multicontrast
MRI data, conventional MRI measures as well as demographic and behavioral
data as covariates. Results: Quantitative T2 and T2* relaxometry were signifi-
cantly increased in temporal normal-appearing white matter (NAWM) of patients
compared to HC, indicating subtle microedema (P = 0.03 and 0.004). Further-
more, significant T1 and magnetization transfer ratio (MTR) variations in lesions
(mean T1 z-score: 4.42 and mean MTR z-score: 4.09) suggested substantial tis-
sue loss. Combinations of multicontrast and conventional MRI data significantly
predicted cognitive fatigue (P = 0.01, Adj-R2 = 0.4), attention (P = 0.0005,
Adj-R2 = 0.6), and disability (P = 0.03, Adj-R2 = 0.4). Conclusion: Advanced
MRI techniques at 3T, unraveled the nature of brain tissue damage in early MS
and substantially improved clinical–radiological correlations in patients with
minor deficits, as compared to conventional measures of disease.
Introduction
Multiple sclerosis (MS) is an inflammatory and neurode-
generative disease of the central nervous system (CNS)
characterized by the presence of focal lesions in white
matter (WM) and gray matter (GM) and also by diffuse
inflammation and degeneration in normal-appearing
(NA) tissue.1,2 Conventional MRI plays a major role in
identifying focal inflammation and diagnosing MS, but
has important limits in assessing underlying pathology.
As a consequence, this method provides only modest cor-
relations with patient functional performance, particularly
during early phases of the disease.3
In this context, quantitative and semiquantitative
(q/sq) MRI techniques4,5 may provide new biomarkers of
disease severity and help to improve the clinical–radiolog-
ical mismatch in MS treatment. To this end, pathological
processes such as demyelination, edema formation, tissue
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loss, and iron accumulation lead to variable changes in
quantitative measures of proton relaxation times (T1, T2,
and T2*) as well as in semiquantitative parameters such
as the magnetization transfer ratio (MTR).6–10 Thanks to
recent MRI developments,11,12 it is now possible to com-
bine multiple q/sq MRI sequences in a clinically applica-
ble protocol and gather more specific information about
the nature of tissue pathology in MS.
In this work, we investigated whether the combination
of advanced T1, T2, and T2* relaxometry and magnetiza-
tion transfer imaging may be employed (1) to assess the
nature of brain tissue changes occurring early in MS and
(2) to improve the correlation between imaging and clini-
cal performance.
Methods
Study population
We enrolled 36 patients with relapsing-remitting MS
(RRMS), 24 women/12 men, age = 34.8  9.2 years
(mean  standard deviation [SD]) and 18 age-matched
healthy controls (HC), 9 women/9 men, age = 33 
9.7 years. All patients were <6 years from initial symp-
toms (33.3  21 months, range 2–70 months) and dis-
ease diagnosis (27.1  18 months, range 0–59 months).
Thirty patients (83%) were under immunomodulatory
treatment (high dosage interferon beta or fingolimod) for
at least 3 months. No patient had received corticosteroid
therapy within the 3 months preceding the enrollment.
The study was approved by the ethics committee of the
Lausanne University Hospital (CHUV). Written, informed
consent was obtained from each subject.
Clinical assessment
Each subject underwent a neurological examination includ-
ing the following cognitive and behavioral tests: (1) Brief
Repeatable Battery of Neuropsychological Tests (BRB-N),13
which examine verbal and spatial memory, sustained atten-
tion, information processing speed, and verbal fluency on
semantic cues; (2) the Hospital Anxiety and Depression scale
(HAD)14; and (3) the Fatigue Scale for Motor and Cognitive
functions (FSMC),15 which quantifies depressive mood
symptoms and fatigue. The Expanded Disability Status Scale
(EDSS16) and the Multiple Sclerosis Functional Composite
(MSFC17) scores were assessed by a certified neurologist (C.
Granziera, CG) to quantify motor performance.
MRI techniques
All MR images were acquired on a 3T Siemens Trio
(Siemens, Erlangen, Germany) equipped with a 32-chan-
nel head coil. The acquisition protocol consisted of: (1)
high-resolution 3D magnetization-prepared acquisition
with gradient echo (MPRAGE) (TR/TE = 2300/2.98 ms,
voxel size = 1.0 9 1.0 9 1.2 mm3, FoV = 256 9 240 9
192 mm3, acquisition time = 5:12 min) for automatic
brain tissue, and atlas-based segmentation as reported
previously18–20; signal-to-noise ratio (SNR) measurements
on a MPRAGE image were performed based on21,22 and
reported in detail in the supplementary data (2) high-res-
olution 3D fluid attenuated inversion recovery (FLAIR)
(TR/TE/TI = 5000/394/1800 ms, voxel size = 1.0 9 1.0 9
1.2 mm3, FoV = 256 9 240 9 212 mm3, acquisition time
= 6:27 min); (3) high-resolution 3D double inversion
recovery (DIR) (TR/TE/TI = 10,000/218/3650 ms, voxel
size = 1.1 9 1.0 9 1.2 mm3, FoV = 256 9 240 9 192
mm3, inversion times 450/3652 ms, acquisition time =
12:52 min); (4) Magnetization-Prepared 2 Rapid Acquisi-
tion Gradient Echoes MP2RAGE12 (TR/TE = 5000/2.89 ms,
voxel size = 1.0 9 1.0 9 1.2 mm3, FoV = 256 9 240
9 212 mm3, acquisition time = 8:22 min) for lesion
count,23 and whole-brain T1 relaxometry; (5) T2 relaxome-
try (TR/TE = 5850/9 ms, 21 echos, 30 slices: voxel
size = 1.0 9 1.0 9 4.0 mm3, FoV = 210 9 175 9 120
mm3, acquisition time = 3 min) using a new nonlinear
inverse reconstruction algorithm that directly estimates a T2
and spin-density map from a train of undersampled spin
echoes11; and finally, (6) T2* relaxometry (TR/TE = 47/
1.23 ms, 32 gradient echoes, voxel size = 1.6 9 1.6 9
1.6 mm3, FoV = 217 9 217 9 179 mm3, acquisition
time = 11:16 min) with and without magnetization trans-
fer (MT) pulse (MT pulse flip angle: 220°; duration:
4000 ms; pulse offset: 2000 Hz; spoiler moment: 25,000
us 9 mT/m24). In order to correct for susceptibility
induced macroscopic field inhomogeneities, which were
already diminished by isotropic high-spatial resolution, we
used a 3D Sinc Correction25 that was extended to include a
nonlinear correction term based on the underlying B0
map26; The B0 map was calculated as the weighted mean
phase difference27 of the temporally unwrapped phase fol-
lowed by a median and Gaussian filters to remove phase
inconsistencies.28 R20 maps were computed from T2 and
T2* maps according to
R20 ¼ 1
T2
 1
T2
MTR maps were derived from the T2* data by
MTR ¼ M0 MT
M0
with M0 and MT the images acquired without and with MT
pulse, respectively. MT images were registered to images
without MT pulse. Before any processing, image quality
was assessed for each modality by visual inspection.
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Figure 1 provides an example of all images and maps
in one HC and one MS subject.
Raw data from a HC are available in Data S1.
Total scan time was ~47 min.
MRI contrasts
T1 relaxation time (rt) in brain tissue is mainly influ-
enced by free water protons and the degree of structural
Figure 1. MP2RAGE uniform image, MPRAGE, DIR, 3D FLAIR images as well as MP2RAGE T1, T2, T2*, and MTR maps for one healthy control
subject (first two raws) and one MS patient (last two raws). Examples of lesions are shown by red arrows in the images from the MS patient.
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organization (i.e. amount of macromolecules such as
myelin, lipids, proteins). In this context, an increase in
T1rt may indicate a loss of structure and/or an increase
in water content. Conversely, greater density of macro-
molecules and reduced water content as well as iron accu-
mulation tend to reduce T1.29
T2rt measures the loss of spin coherence, and therefore,
mainly reflect the dynamic state of water protons and
their interaction with macromolecules. An increase in
T2rt characterizes a loss of macromolecules and/or
increased water content. On the contrary, a decrease in
T2rt reflects an increase in protons bound to macromole-
cules. As for T1, iron accumulation also causes a shorter
T230 (Fig. 1).
The effective T2* transverse rt describes the loss of
transverse magnetization due to T2 relaxation and mag-
netic field inhomogeneities (R20 component31). Possible
sources are tissue-dependent differences in magnetic sus-
ceptibility or the presence of paramagnetic or ferromag-
netic ions like iron. For these reasons, an increase in T2*
most often indicates a loss of macromolecules, while a
decrease suggests an increase in macromolecular com-
pounds or iron that translate into an increase in R20.
MT images are based on the interaction between free
protons and immobilized protons bound to macromole-
cules, so that a lower MTR indicates a reduced spin
exchange between macromolecules and surrounding bulk
water suggesting neuroaxonal damage or myelin break-
down32 and/or water increase.
Image analysis and tissue segmentation
We used the Elastix c++ library33 to perform (1) rigid
registration with BSpline interpolation of the T2 maps to
the T1 maps (from the MP2RAGE); and (2) rigid regis-
tration of T2* maps, MPRAGE, FLAIR, and DIR images
to one of the inverted contrasts of the MP2RAGE
sequence. By doing this, we obtained all images in the
MP2RAGE space.
Regions of interest (ROIs) were derived from the
MPRAGE image using in-house software based on varia-
tional expectation-maximization tissue classification.34
The following ROIs were automatically segmented: whole-
brain WM and cortical GM, thalamus, and basal ganglia
(caudate, putamen, and globus pallidus), cerebellar WM
and GM. In addition, we computed lobar WM and GM
(temporal, occipital, frontal, parietal areas).
An experienced neurologist (CG) and a radiologist (D.
Rotzinger, DR) manually counted MS lesions by consen-
sus in 3D FLAIR, 3D DIR, and MP2RAGE images for all
MS subjects and HC, as performed previously.20 A trained
technician generated manual contours for each lesion in
the three different contrasts (rechecked by DR). In order
to maximize the sensitivity of lesion count and volume,
lesion masks from each contrast were merged into a sin-
gle mask (lesion union mask), as reported by Kober
et al.20
The lesion union mask and the ROIs masks were then
registered to the T1, T2, T2*, and MTR maps to obtain
parametric values in lesions and NA tissue in each ROI.
The volume of each ROI was also automatically
obtained using the in-house software based on a previous
report34 and normalized by total intracranial volume.
Statistical analyses
Between-groups comparisons of subjects’
demographics and clinical scores
Differences in age, gender, education, and clinical perfor-
mance were assessed using a nonparametric ANOVA
(Kruskal–Wallis test) among HC and MS patients.
Between-groups comparisons of multicontrast
MRI data
To assess NA tissue differences in mean T1, T2, T2*, and
MTR of patients and controls, we performed a permuta-
tion-based Hotelling test with 10,000 permutations, age
and gender as covariates, and family-wise correction for
multiple comparisons.
The following null hypotheses were tested: (1) there are
no differences in WM and GM of temporal, parietal,
occipital, and frontal lobes; (2) there are no differences in
cerebellum WM and GM; and (3) there are no differences
in thalamus and basal ganglia.
Lobar assessment was chosen, instead of whole brain,
to take into account the local variation in quantitative re-
laxometry measures, as reported previously.35,36
In order to determine the strength of the significance,
we also calculated the Cohen’s d effect size as follow:
d ¼ x1  x2
s
with x1 and x2 the mean of the group 1 (HC) and group
2 (RRMS), and s defined as follows:
s ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðn1  1Þs21 þ ðn2  1Þs22
n1 þ n2  2
s
Parameters s1 and s2 refer to the standard deviation of
group 1 (HC) and group 2 (RRMS), while n1 and n2 are
the number of samples of group 1 and 2.
In order to compare lesional tissue, MRI properties in
patients with the corresponding healthy tissue in HC, we
calculated a z-score for each lesion and then averaged the
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lesion z-scores across all lesions in each subject as follows
(i.e. for T1 data):
zT1 ¼ 1
N
X
l2fLesionsg
X
m2l
IT1ðvÞ  lT1ðLl;TlÞ
rT1ðLl;TlÞ
where zT1 corresponds to the average of T1 lesion z-scores
in one patient, N to a normalization term, IT1 the T1
map, lT1(Ll, Tl) and rT1(Ll, Tl) to the mean and the stan-
dard deviation of T1 in the lobe Ll and tissue Tl (i.e. WM
or GM) in the HC group, corresponding to the lesion
location. Averages of each patient’s T1, T2, T2*, and
MTR lesion z-scores were also performed in the whole
MS group.
This approach was chosen instead of the permutation-
based test applied for NA tissue to account for spatial
variation in relaxometry values.35,36 A permutation test
was not feasible for each lobe as not all patients exhibited
lesions in all lobes.
Between-groups comparison of volumes
To assess volumetric differences in ROIs’ between patients
and controls, we performed a permutation-based Hotell-
ing test with 10,000 permutations, age and gender as co-
variates, and family-wise correction for multiple
comparisons.
Linear regression of MRI parameters with clinical
scores
All regression analyses were performed using R software
(http://www.R-project.org).
A multivariate linear regression of clinical scores was
performed using a general linear model (GLM) applied
(1) T2*, T2, T1, and MTR in the ROIs that differed
between patients and HC, (2) T1, T2, T2*, and MTR
lesion z-scores and (3) cortical/subcortical lesion count
and volume. Age, gender, educational years, anxiety, and
depression scores (HAD) were considered as covariates,
since they have been reported to be linked to functional
performance.37,38 Cognitive scores were adapted using
Box–Cox transformation to satisfy model assumption for
normality.39 EDSS scores were not considered, as they
were positive only in patients.
We performed seven regressions, where we used a
backward stepwise approach to select the best prediction
model for each dependent variable (clinical scores). Bon-
ferroni correction was applied for multiple comparisons
(seven tests).
Cook’s distance (Cd) was computed to assess the influ-
ence of each observation on the regression process, using
4/n (n: number of observations) as the threshold of
significance. Robust regression was used to reduce influ-
ence of the outliers identified by Cook’s distance analysis.
“Leave-one-out” (LOO) cross-validation was applied to
assess the prediction quality and robustness of each
model. A P < 0.05 was considered statistically significant.
Results
Between-groups comparisons of subject
demographics and clinical scores
No significant differences were observed between HC and
MS patients in terms of age (P = 0.3) or gender
(P = 0.8); however, HC had slightly higher education lev-
els (17  4 years, mean  standard deviation) than MS
patients (15  3 years, P = 0.04).
Mean EDSS in patients was 1.6  0.3 (interval: 1–2).
The FSMC motor score was significantly higher in MS
patients (23.1  10.5) than in HC (14.8  5.8, P < 0.02).
The FSMC cognitive scores, cognitive performance, MSFC
scores, as well as anxiety and depression scores (HAD)
were not significantly different between groups (P > 0.1).
Between-groups comparison of
multicontrast MRI data
In temporal NAWM, mean T2* and T2 were significantly
higher in RRMS patients compared to HC (T2* rt:
55.1  1.55 msec in patients and 53.4  1.35 msec in HC,
d = 1.17, P = 0.004, Fig. 2; T2 rt: 82.0  2.38 msec in
patients and 79.8  2.0 msec in HC, d = 1, P = 0.03, Fig. 2).
In order to assess whether the observed T2* increase in
temporal NAWM depended on local field inhomogenei-
ties, we also compared temporal NAWM R20 between
groups and found no significant differences.
Additionally, parietal NAWM and cerebellar NAWM
exhibited a trend toward higher T2 values in patients
compared to HC (parietal NAWM T2: 83.5  2.44 msec
in patients compared to 81.8  2.62 msec in HC;
d = 0.7, P = 0.05; and cerebellar WM T2: 85.90 
1.69 msec in patients compared to 85.48  1.47 msec in
HC; d = 1.62, P = 0.07).
Further, no differences were seen for T1 and MTR in
NAWM and cortical NAGM, nor for T2 and T2* in cor-
tical NAGM, frontal or occipital NAWM. Finally, no sig-
nificant differences between groups were found for T1,
MTR, T2, or T2* in the thalamus or basal ganglia.
Results of microstructural analysis of lesions are
reported in Figure 3.
In the MS cohort, MS lesions showed a strong increase
in T1 mean z-score (4.42) and an important decrease in
MTR mean z-score (4.09). T2 and T2* mean z-scores
slightly increased (2.33 and 2.25, respectively).
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Figure 2. (A) (Top): T2* and T2 mean histograms in NAWM (temporal lobe) for HC (blue) and MS patients (red); (B) (Below): Boxplot of T2* and
T2 in NAWM (temporal lobe) for HC (left) and MS patients (right).
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Between-groups comparison of volumes
No significant differences were observed in volumes
between MS patients and HC, however, there was a trend
toward smaller normalized thalamic volumes in patients
(absolute volume 15.31  1.36 mm3, normalized volume
0.01  0.0006) compared to HC (absolute volume 16.52 
2.04 mm3, normalized volume 0.01  0.0003 P = 0.07).
Linear regression of MRI parameters with
clinical scores
GLM using backward, stepwise regression revealed a
highly significant association, confirmed by cross-valida-
tion results, between multicontrast MRI features and four
clinical scores (Table 1):
1 Cortical lesions count and volume, T1, T2, and T2*
mean z-score of lesions, T1, T2*, and MTR mean of
temporal NAWM together with gender predicted the
Symbol Digit Modalities Test (attention function) score
(adjusted R2: 0.6, P = 0.0005).
2 T2, T2*, and MTR mean in temporal NAWM in con-
junction with T1 and T2 mean z-score in lesions as
well as subcortical lesion volume and educational years,
gender and HAD scores predicted the MSFC (general
disability) score (adjusted R2: 0.4, P = 0.03).
3 T1 and T2 mean in temporal NAWM combined with
cortical lesion volume, subcortical lesion count, and
Figure 3. T1, MTR, T2, and T2* mean z-scores per patient (columns) in MS lesion.
Table 1. Multiple regression analysis between lesional and temporal NAWM MRI characteristics, covariates, and clinical scores.
Top part: each line corresponds to the P-values, corrected P-values, and adjusted-R2 of each model (n = 7) subjected to regression and cross-vali-
dation analysis. Bottom part: each line corresponds to the P-values of each predictor for every regression model performed. The color scheme sig-
nifies the difference in significance: dark orange = highest significance (P < 0.001), light orange = middle range significance (P < 0.01), and
yellow = low significance (P < 0.05).
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HADD score predicted the FSMC cognitive score
(adjusted R2: 0.4, P = 0.01).
4 T1 and T2 mean in temporal NAWM combined with
cortical lesion volume, subcortical lesion count, and
volume with HADD score predicted the FSMC motor
score (adjusted R2: 0.4, P = 0.01).
Discussion
The present results demonstrate that combining multiple
advanced MRI techniques, it is possible to unravel the
nature of subtle tissue alterations in early MS. Moreover,
MRI markers of inflammation and neurodegeneration
may substantially improve clinical–radiological correla-
tions compared to conventional measures.
The RRMS patients enrolled in our study exhibited sig-
nificant increases in T2 and T2*rt in temporal NAWM,
and to a lesser extent in parietal and cerebellar NAWM.
These changes hint to an accumulation of extracellular
water (microedema) and/or a reduction in macromolecu-
lar content (myelin) in affected brain tissue (Fig. 2). In
the absence of significant changes in MTR and T1rt,
which would support the structural explanation, the
increase in both T2 and T2*rt most likely indicates the
presence of subtle edema. Iron loss might also be respon-
sible for a prolongation of T2 and T2*rt, but appears to
be a less probable cause as no differences were observed
in R20, which reflects local field inhomogeneities.40
By combining multiple q/sq MRI measures, our study
confirms work reporting T2 increase in NAWM in early
MS6,41 and extends these findings by providing new
insights into the pathology underlying those changes.
However, our data contradict studies showing a measured
unimodal MTR decrease in NAWM of early MS patients
attributed to myelin loss.42,43 These studies focused
mainly on untreated patients and applied MT imaging at
lower spatial resolution and lower field strength (1.5 T)
than ours. Furthermore, unimodal MTR studies in MS
should be considered with caution, as MT imaging alone
cannot discriminate between myelin alterations and varia-
tion in water content in tissues.44
Axonal degeneration in NAWM of early MS patients
was also suggested by unimodal diffusion tensor imaging
(DTI) studies, showing reduced fractional anisotropy
(FA).45,46 Nevertheless, this interpretation may be mis-
leading since a decrease in anisotropy can derive from the
loss of the branched-shape of microglia cells that is typi-
cal of their activated-inflammatory form.47 Thus, another
possible explanation is that reduced FA might point to
inflammatory rather than degenerative phenomena.
Several studies tried to address the limitation of un-
imodality studies by combining T2 relaxometry, MTR
measurements,48 and DTI49; however, these studies
focused on selected brain structures (i.e. corpus callo-
sum49 and corticospinal tract48) in patients with advanced
stages of MS.49 Our approach overcomes the above-men-
tioned limits by performing a whole-brain analysis of
multiple q/sq assessments in early MS.
Our data also showed that both cortical and subcortical
lesions were characterized by a strong increase in T1rt and
decrease in MTR with relatively modest positive variations of
T2 and T2*rt (Fig. 3). These findings are consistent with pre-
vious MRI literature50,51 and histopathological studies9,10,52
showing significant neurodegeneration in MS plaques.
No significant microstructural alterations were found in
NA tissue belonging to the basal ganglia or thalamus in our
MS cohort. Still, volumetric analyses revealed a trend
toward lower regional volumes in patients (P = 0.07),
which is consistent with thalamic atrophy reported in larger
and more heterogeneous patient groups.53
Last, we showed that MRI findings of microstructural
alterations in NA tissue and lesions substantially improved
the clinical–radiological correlation obtained with conven-
tional measures, even in the presence of minor functional
deficits. In fact, a variable combination of relaxometry and
MTR values significantly ameliorated the prediction of cog-
nitive performance (attention), cognitive fatigue, and gen-
eral disability obtained with traditional measures of disease
burden and patient covariates (Table 1).
Conventional MRI measures of MS disease impact pro-
vide only modest correlations with clinical performances, a
phenomenon that is known as the clinico-radiological par-
adox. Multivariate analyses and multicontrast, tract-specific
measures were proposed to alleviate this paradox,48,49 but
suffered from the limitations of conventional protocols and
partial brain analyses. Recently, ultra-high field MRI at 7 T
has been used to identify subtypes of cortical lesions, whose
numbers showed good correlations with disability and cog-
nitive performance in MS.54 Extending such work, the mul-
ticontrast approach presented here emerges as a whole-
brain MRI method at a clinically-compatible magnetic
field, which produces strong clinical-radiological correla-
tions for both cognition and disability.
Future developments should aim at reducing the num-
ber of sequences required for optimal lesion detection
(i.e. MP2RAGE and 3DFLAIR23) as well as at applying
accelerated T1-T2* relaxometry sequences to achieve a
well-suited protocol for the clinical workflow.
In summary, combining multiple recent MRI techniques
at 3T we found (1) increased T2 and T2* in temporal
NAWM, suggesting subtle microedema; (2) a strong
increase in T1rt and decrease in MTR in lesions, indicating
prevalent tissue degeneration; and (3) improved correla-
tions between MRI data and measures of cognition and dis-
ability in early and minimally impaired MS patients.
Additional studies extending the current methods to
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patients at later disease stages and containing larger cohorts
will be necessary in the future.
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